Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study-Reference-Cited by-同舟云学术

Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study

Published:2023-01 Issue: Volume:55 Page:101751
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Yang Aimin,Shi Mai,Lau Eric S.H.^ORCID,Wu Hongjiang,Zhang Xinge,Fan Baoqi^ORCID,Kong Alice P.S.,Luk Andrea O.Y.,Ma Ronald C.W.^ORCID,Chan Juliana C.N.,Chow Elaine^ORCID

Funder

Chinese University of Hong Kong

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N Engl J Med,2001

2. Effects of ramipril on coronary events in high-risk persons;Dagenais;Circulation,2001

3. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med,2001

4. Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate;Qiao;JAMA Intern Med,2020

5. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study;Fu;J Am Soc Nephrol,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes;JAMA Internal Medicine;2024-08-12

2. Stratifying heart failure patients with graph neural network and transformer using Electronic Health Records to optimize drug response prediction;Journal of the American Medical Informatics Association;2024-06-26

3. Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality;Journal of the American Society of Nephrology;2024-06-18

4. Dose and Time Effects of Renin–Angiotensin Inhibitors on Patients With Advanced Stages 4 to 5 of Diabetic Kidney Disease;Journal of the Endocrine Society;2024-06-11

5. Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability;Diabetes, Obesity and Metabolism;2024-05-27